Watson Pharmaceuticals News

Stocks in this week's article are G-III Apparel Group , Inverness Medical and Watson Pharmaceuticals .

Israeli generic-drug maker Teva Pharmaceutical Industries Ltd. agreed to acquire U.S. peer Barr Pharmaceuticals Inc.

West, the world's premier manufacturer of components and systems for injectable drug delivery, announced that Watson Pharma, Inc., a subsidiary of Watson Pharmaceuticals, Inc., has selected MixJect as the new ...

Smith & Nephew appoints Non-Executive Director 10 July 2008 Smith & Nephew plc , the global medical technology business, announces the appointment of an additional Non-Executive Director to the Board.

Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced recently that it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for ...

Watson reveals drug data results Watson Pharmaceuticals Inc., a specialty pharmaceutical company, has announced that investigators presented clinical data on two Phase 3 products at the American Urological ...

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced recently that its New Drug Application for oxybutynin chloride topical gel , has been accepted for filing by the U.S. Food and ...

Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that investigators presented clinical data on two Phase 3 products at the American Urological Association's annual ...

“He wants to devote more time to personal work and some personal business ventures”

Allen Chao, the man most responsible for building Watson Pharmaceuticals Inc. into a successful international corporation, resigned as chairman of the board Monday, the company said in a statement. via The Press-Enterprise

“The new MIXJECT drug delivery system was designed with a smaller needle size and updated features that promote OSHA compliance based on the needs and suggestions from our customers in collaboration with our partner, West.”

Watson Pharmaceuticals, Inc. WPI, a leading specialty pharmaceutical company, announced recently that the U.S. Food and Drug Administration has approved MIXJECT, the new delivery system for TRELSTAR , a ... via Pharmaceutical Online

“The new MIXJECT(TM) drug delivery system was designed with a smaller needle size and updated features that promote OSHA compliance based on the needs and suggestions from our customers in collaboration with our partner, West.”

Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has approved MIXJECT , the new delivery system for TRELSTAR , a palliative ... via BioSpace

Office Depot was up $1.04, or 8.7 percent, to $13.00. The world's second-largest office-supplies retailer said first-quarter net income fell on lower sales at its North American stores. via San Jose Mercury News

Shares of Watson Pharmaceuticals spiked 8 percent Tuesday, after the Food and Drug Administration ended its years-long scrutiny of the drug maker's Davie, Fla., manufacturing plant, allowing products made there ... via International Business Times

Bayer AG said Monday that two of its units have filed a lawsuit in the United States against Watson Pharmaceuticals and Sandoz over their applications to U.S. regulators to market a generic version of the oral ... via PR-inside.com

Watson Pharmaceuticals Inc. Monday said it filed an abbreviated new drug application with the Food and Drug Administration seeking approval to market a generic version of Bayer HealthCare Pharmaceuticals's ... via Quamnet

At year end 2007 they marketed more than 150 generic and 27 branded drugs. WPI had an excellent year in 2007 with EPS [from continuing operations] rising 33% Each of the past four quarters showed positive ... via Seeking Alpha

Main Category: Sexual Health / STDs Also Included In: Women's Health / Gynecology Watson Pharmaceuticals said Thursday that it has filed an FDA application to market its generic form of the period-free oral ... via MediLexicon

PR Newswire reported today, March 5, 2008: Barr Pharmaceuticals, Inc. today announced that its wholly-owned subsidiary, Duramed Pharmaceuticals, Inc., has filed suit against Watson Pharmaceuticals and its ... via Philip Brooks' Patent Infringement Up...

Main Category: Pharma Industry / Biotech Industry Also Included In: Women's Health / Gynecology ; Sexual Health / STDs ; Medical Malpractice / Litigation Article Date: 07 Mar 2008 - 6:00 PST newsletters Barr ... via Medical News Today

Cathedral Healthcare System Inc. has agreed to pay the United States $5.3 million plus interest to settle allegations that it defrauded the federal Medicare program, the Federal Justice Department has ... via NJ Biz